Analysis of congenital hearing loss after neonatal hearing screening.

Gill Verstappen, Ina Foulon, Kelsey Van den Houte, Emilie Heuninck, Bart Van Overmeire, Frans Gordts, Vedat Topsakal
Author Information
  1. Gill Verstappen: Department of Otorhinolaryngology-Head and Neck Surgery, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Health Campus, Brussels, Belgium.
  2. Ina Foulon: Department of Otorhinolaryngology-Head and Neck Surgery, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Health Campus, Brussels, Belgium.
  3. Kelsey Van den Houte: Department of Otorhinolaryngology-Head and Neck Surgery, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Health Campus, Brussels, Belgium.
  4. Emilie Heuninck: Department of Otorhinolaryngology-Head and Neck Surgery, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Health Campus, Brussels, Belgium.
  5. Bart Van Overmeire: Medical Department/Preventive Medicine, Kind en Gezin-Opgroeien, Vlaamse Overheid, Brussels, Belgium.
  6. Frans Gordts: Department of Otorhinolaryngology-Head and Neck Surgery, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Health Campus, Brussels, Belgium.
  7. Vedat Topsakal: Department of Otorhinolaryngology-Head and Neck Surgery, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Health Campus, Brussels, Belgium.

Abstract

Introduction: Neonates undergo neonatal hearing screening to detect congenital hearing loss at an early stage. Once confirmed, it is necessary to perform an etiological workup to start appropriate treatment. The study objective was to assess the different etiologies, risk factors, and hearing results of infants with permanent hearing loss and to evaluate the efficacy and consequences of the different screening devices over the last 21 years.
Methods: We conducted a single-center retrospective cohort analysis for all neonatal hearing screening program referrals and performed an etiological workup in case of confirmed hearing loss. We analyzed the evolution of the etiological protocols based on these results.
Results: The governmental neonatal hearing screening program referred 545 infants to our center. Hearing loss was confirmed in 362 (66.4%) infants and an audiological workup was performed in 458 (84%) cases. 133 (24.4%) infants were diagnosed with permanent hearing loss. Ninety infants (56 bilateral and 34 unilateral) had sensorineural hearing loss, and the degree was predominantly moderate or profound. The most common etiology in bilateral sensorineural hearing loss was a genetic etiology (32.1%), and in unilateral sensorineural hearing loss, an anatomical abnormality (26.5%). Familial history of hearing loss was the most frequently encountered risk factor.
Conclusion: There is a significant number of false positives after the neonatal hearing screening. Permanent hearing loss is found only in a limited number of infants. During the 21 years of this study, we noticed an increase in etiological diagnoses, especially genetic causes, due to more advanced techniques. Genetic causes and anatomical abnormalities are the most common etiology of bilateral and unilateral sensorineural hearing loss, respectively, but a portion remains unknown after extensive examinations.

Keywords

References

  1. Ugeskr Laeger. 2003 Feb 3;165(6):574-9 [PMID: 12608025]
  2. Mutat Res. 2009 Mar-Jun;681(2-3):189-196 [PMID: 18804553]
  3. Hum Mutat. 2016 Aug;37(8):812-9 [PMID: 27068579]
  4. Nat Rev Dis Primers. 2017 Jan 12;3:16094 [PMID: 28079113]
  5. Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21104-9 [PMID: 21078986]
  6. J Pediatr. 2008 Jul;153(1):84-8 [PMID: 18571542]
  7. Acad Pediatr. 2012 May-Jun;12(3):171-80 [PMID: 22583631]
  8. B-ENT. 2013;Suppl 21:9-15 [PMID: 24383218]
  9. Pediatrics. 2008 Feb;121(2):e335-43 [PMID: 18187812]
  10. Otol Neurotol. 2018 Jul;39(6):732-738 [PMID: 29889784]
  11. Int J Pediatr Otorhinolaryngol. 2016 Nov;90:251-258 [PMID: 27729144]
  12. B-ENT. 2005;1(3):125-35 [PMID: 16255497]
  13. Genet Med. 2019 Nov;21(11):2614-2630 [PMID: 31171844]
  14. Int J Pediatr Otorhinolaryngol. 2011 Apr;75(4):513-7 [PMID: 21292333]
  15. J Pediatr. 2018 Aug;199:144-150.e1 [PMID: 29681450]
  16. B-ENT. 2007;3(4):185-90 [PMID: 18265723]
  17. Semin Neonatol. 2001 Dec;6(6):521-9 [PMID: 12014893]
  18. BMJ. 2001 Sep 8;323(7312):536-40 [PMID: 11546698]
  19. N Engl J Med. 2006 May 18;354(20):2151-64 [PMID: 16707752]
  20. Eur J Pediatr. 2010 Nov;169(11):1353-60 [PMID: 20549232]
  21. Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):186-92 [PMID: 16490877]
  22. J Clin Virol. 2008 Feb;41(2):57-62 [PMID: 17959414]
  23. Int J Audiol. 2012 Jan;51(1):54-7 [PMID: 22212024]
  24. Otol Neurotol. 2009 Oct;30(7):943-9 [PMID: 19730140]
  25. Otol Neurotol. 2009 Aug;30(5):604-8 [PMID: 19546828]
  26. Lancet. 2005 Mar 5-11;365(9462):879-90 [PMID: 15752533]
  27. Int J Pediatr Otorhinolaryngol. 2016 Nov;90:29-36 [PMID: 27729148]
  28. Int J Audiol. 2012 Jul;51(7):519-28 [PMID: 22686437]
  29. Hum Genet. 2016 Apr;135(4):441-450 [PMID: 26969326]
  30. Eur J Pediatr. 2019 Aug;178(8):1195-1205 [PMID: 31152317]

Word Cloud

Created with Highcharts 10.0.0hearinglossscreeningneonatalinfantssensorineuralcongenitaletiologicalconfirmedworkupbilateralunilateraletiologygeneticstudydifferentriskresultspermanent21yearsprogramperformed4%commonanatomicalnumbercausesIntroduction:NeonatesundergodetectearlystagenecessaryperformstartappropriatetreatmentobjectiveassessetiologiesfactorsevaluateefficacyconsequencesdeviceslastMethods:conductedsingle-centerretrospectivecohortanalysisreferralscaseanalyzedevolutionprotocolsbasedResults:governmentalreferred545centerHearing36266audiological45884%cases13324diagnosedNinety5634degreepredominantlymoderateprofound321%abnormality265%FamilialhistoryfrequentlyencounteredfactorConclusion:significantfalsepositivesPermanentfoundlimitednoticedincreasediagnosesespeciallydueadvancedtechniquesGeneticabnormalitiesrespectivelyportionremainsunknownextensiveexaminationsAnalysisCMVinfectiondeafness

Similar Articles

Cited By